The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
Abstract
Early detection of neurodegenerative disorders would provide clues to the underlying pathobiology of these diseases and would enable more effective diagnosis and treatment of patients. Recent advances in molecular neuroscience have begun to provide the tools to detect diseases like Alzheimer's disease, Parkinson's disease, and others early in their course and potentially even before the development of clinical manifestations of disease. These genetic, imaging, clinical, and biochemical tools are being validated in a number of studies. Early detection of these slowly progressive diseases offers the promise of presymptomatic diagnosis and, ultimately, of disease-modifying medications for use early in disease and during the presymptomatic period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Self-citationMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,851
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
The Prevention of Acute Gastric Ulcer in the Rat by α-Methyldopa
Djahanguiri, B., Hemmati, S., Sadeghi, D., & Firouzabadi, A. (1967) · Pharmacology · doi:10.1159/000137111 · Cited by 783
Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.-C., et al. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 770
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., & Mufson, E. J. (2002) · Annals of Neurology · doi:10.1002/ana.10069 · Cited by 686
Self-citationIncidence and outcome of mild cognitive impairment in a population-based prospective cohort
Larrieu, S., Letenneur, L., Orgogozo, J. M., Fabrigoule, C., Amieva, H., Le Carret, N., Barberger–Gateau, P., & Dartigues, J. F. (2002) · Neurology · doi:10.1212/01.wnl.0000034176.07159.f8 · Cited by 668
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629
Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis
Rosas, H. D., Koroshetz, W. J., Chen, Y. I., Skeuse, C., Vangel, M., Cudkowicz, M. E., Caplan, K., Marek, K., Seidman, L. J., Makris, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000065888.88988.6e · Cited by 505
Self-citationCholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
Davis, K. L. (1999) · JAMA · doi:10.1001/jama.281.15.1401 · Cited by 492
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
New Frontiers in Alzheimer's Disease Genetics
Tanzi, R. E., & Bertram, L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00476-7 · Cited by 463
Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C., & Rossor, M. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05408-3 · Cited by 455
Quantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2000) · Neurology · doi:10.1212/wnl.55.12.1847 · Cited by 397
Self-citationRiley, K. P., Snowdon, D. A., & Markesbery, W. R. (2002) · Annals of Neurology · doi:10.1002/ana.10161 · Cited by 392
Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease: A Prospective Community Study
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.853 · Cited by 369
Self-citationMarek, K. L., Seibyl, J. P., Zoghbi, S. S., Zea-Ponce, Y., Baldwin, R. M., Fussell, B., Charney, D. S., van Dyck, C., Hoffer, P. B., & Innis, R. B. (1996) · Neurology · doi:10.1212/wnl.46.1.231 · Cited by 365
Self-citationSnow, B. J., Tooyama, I., McGeer, E. G., Yamada, T., Calne, D. B., Takahashi, H., & Kimura, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340304 · Cited by 336
Klunk, W. E., Wang, Y., Huang, G.-F., Debnath, M. L., Holt, D. P., Shao, L., Hamilton, R. L., Ikonomovic, M. D., DeKosky, S. T., & Mathis, C. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02086.2003 · Cited by 309
Self-citationPiccini, P., Burn, D. J., Ceravolo, R., Maraganore, D., & Brooks, D. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<577::aid-ana5>3.0.co;2-o · Cited by 304
Berendse, H. W., Booij, J., Francot, C. M. J. E., Bergmans, P. L. M., Hijman, R., Stoof, J. C., & Wolters, E. C. (2001) · Annals of Neurology · doi:10.1002/ana.1049 · Cited by 299
Alzheimer's disease: a correlative study.
Neary, D., Snowden, J. S., Mann, D. M., Bowen, D. M., Sims, N. R., Northen, B., Yates, P. O., & Davison, A. N. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.3.229 · Cited by 275
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
van Dyck, C. H., Seibyl, J. P., Malison, R. T., Laruelle, M., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00005 · Cited by 251
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Morrish, P. K., Sawle, G. V., & Brooks, D. J. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.6.597 · Cited by 245
1 H NMR spectroscopy studies of Huntington's disease: Correlations with CAG repeat numbers
Jenkins, B. G., Rosas, H. D., Chen, Y.-C. I., Makabe, T., Myers, R., MacDonald, M., Rosen, B. R., Beal, M. F., & Koroshetz, W. J. (1998) · Neurology · doi:10.1212/wnl.50.5.1357 · Cited by 238
Detection of neuritic plaques in Alzheimer’s disease by magnetic resonance microscopy
Benveniste, H., Einstein, G., Kim, K. R., Hulette, C., & Johnson, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14079 · Cited by 238
A transgenic mouse model of the ubiquitin/proteasome system
Lindsten, K., Menéndez-Benito, V., Masucci, M. G., & Dantuma, N. P. (2003) · Nature Biotechnology · doi:10.1038/nbt851 · Cited by 234
Five-Year Follow-up of Cognitive Impairment With No Dementia
Tuokko, H., Frerichs, R., Graham, J., Rockwood, K., Kristjansson, B., Fisk, J., Bergman, H., Kozma, A., & McDowell, I. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.577 · Cited by 227
Bioinformatics in the post-sequence era
Kanehisa, M., & Bork, P. (2003) · Nature Genetics · doi:10.1038/ng1109 · Cited by 224
Mild cognitive impairment : aging to Alzheimer's disease
Petersen, R. C. (2003) · Cited by 223
Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging
Poduslo, J. F., Wengenack, T. M., Curran, G. L., Wisniewski, T., Sigurdsson, E. M., Macura, S. I., Borowski, B. J., & Jack, C. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0550 · Cited by 215
Clinical markers of early disease in persons near onset of Huntington’s disease
Paulsen, J. S., Zhao, H., Stout, J. C., Brinkman, R. R., Guttman, M., Ross, C. A., Como, P., Manning, C., Hayden, M. R., Shoulson, I., et al. (2001) · Neurology · doi:10.1212/wnl.57.4.658 · Cited by 204
Mild Cognitive Impairment: Aging to Alzheimer’s Disease
(2003) · doi:10.1093/oso/9780195123425.001.0001 · Cited by 201
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
Doty, R. L., Bromley, S. M., & Stern, M. B. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0011 · Cited by 187
Can we discover novel pathways using metabolomic analysis?
Weckwerth, W., & Fiehn, O. (2002) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(02)00299-9 · Cited by 170
Spiral Analysis: A New Technique for Measuring Tremor With a Digitizing Tablet
Pullman, S. L. (2008) · Movement Disorders · doi:10.1002/mds.870131315 · Cited by 165
Eidelberg, D., Moeller, J. R., Ishikawa, T., Dhawan, V., Spetsieris, P., Chaly, T., Belakhlef, A., Mandel, F., Przedborski, S., & Fahn, S. (1995) · Neurology · doi:10.1212/wnl.45.11.1995 · Cited by 163
Significant Linkage of Parkinson Disease to Chromosome 2q36-37
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M., & Foroud, T. (2003) · The American Journal of Human Genetics · doi:10.1086/374383 · Cited by 161
Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease
Montine, T. J., Quinn, J. F., Milatović, D., Silbert, L. C., Dang, T. N. T., Sanchez, S. C., Terry, E. S., Roberts, L. J., Kaye, J. A., & Morrow, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10272 · Cited by 157
The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus
Niznik, H. B., Fogel, E. L., Fassos, F. F., & Seeman, P. M. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02580.x · Cited by 154
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
Djoussé, L., Knowlton, B., Hayden, M., Almqvist, E. W., Brinkman, R., Ross, C., Margolis, R., Rosenblatt, A., Durr, A., Dode, C., et al. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20190 · Cited by 135
The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease
Tiraboschi, P., Hansen, L. A., Alford, M. F., Masliah, E., Thal, L. J., & Corey‐Bloom, J. (2000) · Neurology · doi:10.1212/wnl.55.9.1278 · Cited by 130
Piccini, P. P., Morrish, P., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J., & Brooks, D. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410213 · Cited by 125
Mouse and fly models of neurodegeneration
Zoghbi, H. Y., & Botas, J. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02729-4 · Cited by 119
DeKosky, S. T., Ikonomović, M. D., Wang, X., Farlow, M. R., Wisniewski, S. R., López, O. L., Becker, J. T., Saxton, J. A., Klunk, W. E., Sweet, R. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10414 · Cited by 98
Self-citationSerum Creatinine Levels Correlate With Plasma Amyloid β Protein
Arvanitakis, Z., Lucas, J. A., Younkin, L. H., Younkin, S. G., & Graff‐Radford, N. R. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200207000-00009 · Cited by 86
Accuracy of family history data on Parkinson’s disease
Marder, K. S., Levy, G., Louis, E. D., Mejia‐Santana, H., Cote, L. J., Andrews, H., Harris, J. M., Waters, C., Ford, B., Frucht, S. J., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000074784.35961.c0 · Cited by 77
Clinical features and neuroimaging of PARK7‐linked parkinsonism
Dekker, M. C. J., Bonifati, V., Swieten, J. C. V., Leenders, N., Galjaard, R. H., Snijders, P. J. L. M., Horstink, M. W. I. M., Heutink, P., Oostra, B. A., & van Duijn, C. M. (2003) · Movement Disorders · doi:10.1002/mds.10422 · Cited by 74
Montgomery, E. B., Koller, W. C., LaMantia, T. J. K., Newman, M. C., Swanson‐Hyland, E., Kaszniak, A. W., & Lyons, K. (2000) · Movement Disorders · doi:10.1002/1531-8257(200005)15:3<467::aid-mds1007>3.0.co;2-# · Cited by 72
Association Study of Parkin Gene Polymorphisms With Idiopathic Parkinson Disease
Oliveira, S. A., Scott, W. K., Nance, M., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K. E., Pahwa, R., Stern, M. B., Hiner, B. C., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.975 · Cited by 62
Subclinical ognitive impairment: Epidemiology and clinical characteristics
Ritchie, K. A., Ledésert, B., & Touchon, J. (2000) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(00)80010-3 · Cited by 59
Validity of family history data on PD
Elbaz, A., McDonnell, S. K., Maraganore, D. M., Strain, K. J., Schaid, D. J., Bower, J. H., Ahlskog, J. E., & Rocca, W. A. (2003) · Neurology · doi:10.1212/01.wnl.0000068007.58423.c2 · Cited by 58
Heertum, R. L. V., & Tikofsky, R. S. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127294 · Cited by 56
Neurological disease: UPS stops delivering!
Miller, R. J., & Wilson, S. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00011-1 · Cited by 33
Overview of the genetics of parkinsonism.
Gasser, T. (2003) · PubMed · Cited by 33
Functional imaging studies in corticobasal degeneration.
Brooks, D. J. (2000) · PubMed · Cited by 27
Parkinson’s Genetics: Molecular Insights for the New Millennium
Skipper, L. M., & Farrer, M. J. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00038-4 · Cited by 21
Dawson, V. L. (2000) · Science · doi:10.1126/science.288.5466.631 · Cited by 14
Dopaminergic Dysfunction in Parkinsonism: New Lessons from Imaging
MAREK, K. L. (1999) · The Neuroscientist · doi:10.1177/107385849900500519 · Cited by 14
Self-citationPotential of Human Embryonic Stem Cells in Regenerative Medicine
Passier, R. C. (2003) · Hormone Research in Paediatrics · doi:10.1159/000074494 · Cited by 13
Cited by
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Dickerson, B. C., Salat, D. H., Greve, D. N., Chua, E. F., Rand-Giovannetti, E., Rentz, D. M., Bertram, L., Mullin, K., Tanzi, R. E., Blacker, D., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000171450.97464.49 · Cited by 910
Metadata
- Authors
- DeKosky, S. T., & Marek, K.
- Venue
- Science
- Published
- 2003-10-31
- Volume
- 302
- Issue
- 5646
- Pages
- 830-834
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1970130998
- Cited by
- 406
- References
- 82
- FWCI
- 11.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.